AMN Healthcare Services, Inc. AMN R2K

Healthcare · Medical Care Facilities · United States

https://www.amnhealthcare.com

AMN Healthcare Services, Inc. provides technology-enabled healthcare workforce solutions and staffing services to acute and sub-acute care hospitals, and other healthcare facilities in the United States. It operates through three segments: Nurse and Allied Solutions, Physician and Leadership Solutions, and Technology and Workforce Solutions. It offers travel nurse staffing, labor disruption staffing, local staffing, international nurse permanent placement, allied staffing, crisis nurse staffing for critical staffing and rapid response nursing, and allied health professionals, such as skilled nursing facilities, rehabilitation clinics, schools, and pharmacies, as well as physician and advanced practice staffing, and revenue cycle solutions. The company also provides allied health professionals, such as physical therapists, respiratory therapists, occupational therapists, medical and radiology technologists, lab technicians, speech pathologists, rehabilitation assistants, and pharmacists; and solutions for schools, including teletherapy platform, Televate, and qualified school speech-language pathologists, psychologists, nurses, social workers, and other care providers. In addition, it offers locum tenens staffing, healthcare interim leadership staffing, executive search, and physician permanent placement solutions. Additionally, the company provides language services, vendor management systems, workforce optimization, and outsourced solutions. The company offers its services under the brands, including AMN Healthcare, Nursefinders, O'Grady Peyton International, Connetics, Medical Search International, DRW Healthcare Staffing, and B.E. Smith. AMN Healthcare Services, Inc. was founded in 1985 and is based in Dallas, Texas.

Market & Price

Market Cap

$1.12B

Current Price

$28.97

High / Low (52W)

$30.87 / $15.10

Beta

0.30

Valuation

Stock P/E

Industry PE

23.65

Forward P/E

26.68

PEG Ratio

1.22

Book Value

$18.44

Price to Book

1.57

P/S

0.33

EV/EBITDA

4.62

Dividend Yield

Profitability & Returns

ROCE

-3.66%

ROE

-4.54%

ROA

3.45%

Profit Margin

-0.95%

Op Margin

8.50%

EPS (Latest Qtr)

$1.59

EPS (TTM)

$-0.86

Balance Sheet & Liquidity

Debt/Equity

1.09

Quick Ratio

0.96

Current Ratio

1.09

Debt

$776.92M

Total Assets

$2.09B

Current Assets

$545.38M

Working Capital

$-32.24M

Ownership

Promoter Holding

0.99%

Chg in Prom Hold

0.19%

FII / Inst Holding

115.55%

Chg in FII Hold

0.01%

Financial Snapshot

Enterprise Value

$1.34B

Total Revenue (TTM)

$3.42B

EBITDA

$290.23M

Free Cash Flow

$671.52M

Operating Cash Flow

$739.24M

Shares Outstanding

38.79M

Gross Margin

27.63%

Payout Ratio

0.00%

Growth (CAGR)

Revenue 5Y

-19.55%

Profit 5Y

-40.52%

Revenue (YoY)

99.90%

Earnings (YoY)

PROS

Generates positive free cash flow.
In a confirmed uptrend (50-DMA above 200-DMA).

CONS

Revenue declined at -19.5% CAGR over 5 years.
Earnings shrank at -40.5% CAGR over 5 years.

* The pros and cons are auto-generated from financial metrics.

Price Chart

Robinhood TradingView StockAnalysis

Fundamental Growth

Period: Metric:

Figures from the latest reported periods. CAGR is computed across the displayed window (quarterly CAGR is annualised assuming 4 quarters per year).

Peer comparison

Peer companies in the same sector (Healthcare).

#	Name	CMP $	P/E	Mkt Cap	Div Yld %	ROCE %	ROE %	Rev CAGR 5Y %	Profit CAGR 5Y %
1	AMN AMN Healthcare Services, Inc. R2K	28.97	-	$1.12B	-	-3.66%	-4.54%	-19.55%	-40.52%
2	LLY Eli Lilly and Company SPX	1,105.00	39.21	$985.37B	0.63%	38.44%	107.46%	31.69%	48.96%
3	JNJ Johnson & Johnson SPX	225.33	26.11	$542.42B	2.38%	23.13%	26.42%	5.60%	14.32%
4	UNH UnitedHealth Group Incorporated SPX	380.31	28.66	$345.38B	2.32%	9.60%	12.18%	11.35%	-15.69%
5	MRK Merck & Co., Inc. SPX	118.72	33.44	$293.22B	2.86%	20.66%	18.94%	3.12%	7.93%
6	TMO Thermo Fisher Scientific Inc. SPX	492.51	27.11	$183.03B	0.38%	9.17%	13.52%	-0.27%	-1.19%
7	AMGN Amgen Inc. NDXSPX	336.79	23.42	$181.77B	2.99%	18.02%	101.32%	11.77%	5.58%
8	GILD Gilead Sciences, Inc. NDXSPX	134.43	18.29	$166.90B	2.44%	22.92%	43.36%	2.57%	22.83%
9	ISRG Intuitive Surgical, Inc. NDXSPXAI	424.64	51.53	$150.39B	-	15.96%	17.23%	17.39%	29.26%

Quarterly Results

Figures in USD.

Metric	Jun 2015	Sep 2015	Dec 2015	Mar 2016	Jun 2016	Sep 2016	Dec 2016	Mar 2017	Jun 2017	Sep 2017	Dec 2017	Mar 2018	Jun 2018	Sep 2018	Dec 2018	Mar 2019	Jun 2019	Sep 2019	Dec 2019	Mar 2020	Jun 2020	Sep 2020	Dec 2020	Mar 2021	Jun 2021	Sep 2021	Mar 2022	Jun 2022	Sep 2022	Mar 2023	Jun 2023	Sep 2023	Mar 2024	Jun 2024	Sep 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Revenue	-	-	-	-	-	-	-	495.17M	489.80M	494.41M	509.08M	522.49M	558.11M	526.84M	528.63M	532.44M	535.18M	567.60M	586.89M	602.46M	608.35M	551.63M	631.27M	885.95M	857.45M	877.80M	1.55B	1.43B	1.14B	1.13B	991.30M	853.46M	820.88M	740.68M	-	689.53M	658.17M	634.50M	748.23M	1.38B
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	491.41M	461.78M	450.08M	553.10M	1.01B
Gross Profit	110.12M	126.01M	131.80M	151.90M	154.75M	154.47M	158.61M	161.78M	161.01M	159.54M	162.09M	167.82M	180.96M	175.15M	172.46M	176.76M	179.54M	190.03M	197.13M	202.07M	197.54M	184.63M	207.54M	288.87M	280.54M	305.87M	496.17M	460.24M	385.03M	368.85M	330.28M	289.51M	257.51M	229.83M	-	198.12M	196.40M	184.41M	195.13M	368.84M
Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	185.61M	192.34M	175.97M	186.97M	251.66M
Operating Income	30.16M	37.61M	-	47.31M	47.88M	46.68M	-	52.03M	56.38M	50.83M	-	55.20M	54.81M	42.63M	-	45.05M	45.16M	39.74M	-	35.74M	38.40M	46.46M	-	104.40M	99.17M	105.83M	207.93M	183.53M	136.37M	125.67M	91.66M	86.93M	39.95M	37.68M	-	12.51M	4.06M	8.44M	8.16M	117.17M
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	52.36M	-83.83M	87.25M	45.35M	152.83M
Interest Expense	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	12.32M	11.36M	9.63M	12.28M	6.71M
Pretax Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	183.00K	-135.07M	37.99M	-4.16M	110.46M
Tax Provision	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1.27M	-18.87M	8.70M	3.53M	48.29M
Net Income	15.87M	33.65M	20.16M	25.87M	26.32M	27.30M	26.35M	32.01M	31.25M	28.13M	41.17M	42.68M	35.53M	27.92M	35.61M	34.12M	28.87M	23.52M	27.48M	12.96M	22.32M	26.07M	9.31M	70.38M	66.77M	74.02M	146.01M	123.80M	92.44M	84.11M	60.91M	53.17M	17.33M	16.24M	-	-1.09M	-116.20M	29.29M	-7.70M	62.17M
Diluted EPS	0.32	0.69	0.41	0.53	0.53	0.55	0.54	0.65	0.63	0.57	0.84	0.87	0.73	0.58	0.74	0.71	0.61	0.49	0.58	0.27	0.47	0.55	0.19	1.47	1.39	1.54	3.09	2.77	2.10	2.02	1.55	1.39	0.45	0.42	-	-0.03	-3.02	0.76	-0.20	1.59

Profit & Loss (Annual)

Figures in USD.

Metric	Dec 2009	Dec 2010	Dec 2011	Dec 2012	Dec 2013	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Revenue	-	-	-	-	-	-	-	1.90B	1.99B	2.14B	2.22B	2.39B	3.98B	5.24B	3.79B	2.98B	2.73B
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	3.53B	2.54B	2.06B	1.96B
Gross Profit	204.42M	184.36M	249.32M	270.40M	297.28M	316.12M	469.36M	619.72M	644.42M	696.38M	743.47M	791.78M	1.31B	1.72B	1.25B	919.38M	774.06M
Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	1.07B	903.35M	799.59M	740.89M
Operating Income	-153.61M	-43.78M	37.65M	53.34M	65.50M	67.90M	128.88M	191.63M	212.44M	202.83M	176.91M	149.26M	478.00M	647.10M	346.23M	119.78M	33.17M
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	-	784.21M	499.36M	71.11M	101.13M
Interest Expense	-	-	-	-	-	-	-	-	-	-	-	-	-	40.40M	54.14M	69.90M	45.59M
Pretax Income	-	-	-	-	-	-	-	-	-	-	-	-	-	606.70M	284.29M	-172.57M	-101.06M
Tax Provision	-	-	-	-	-	-	-	-	-	-	-	-	-	162.65M	73.61M	-25.59M	-5.36M
Net Income	-122.18M	-51.99M	-26.27M	17.14M	32.93M	33.22M	81.89M	105.84M	132.56M	141.74M	113.99M	70.67M	327.39M	444.05M	210.68M	-146.98M	-95.70M
Diluted EPS	-3.75	-1.49	-0.57	0.37	0.69	0.69	1.68	2.15	2.68	2.91	2.40	1.48	6.81	9.90	5.36	-3.85	-2.48

Compounded Sales Growth

5 Years:	-19.55%
1 Year:	99.90%

Compounded Profit Growth

5 Years:	-40.52%
1 Year:	-

Stock Price Performance

1 Year:	+37.23%
6 Months:	+65.64%
3 Months:	+48.72%
1 Month:	+36.91%

Balance Sheet (Annual)

Figures in USD.

Metric	Dec 2008	Dec 2009	Dec 2010	Dec 2011	Dec 2012	Dec 2013	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Assets	-	-	562.11M	535.63M	517.39M	604.29M	680.73M	880.43M	1.19B	1.25B	1.49B	1.93B	2.35B	-	2.89B	2.92B	2.42B	2.09B
Current Assets	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1.09B	841.68M	594.91M	545.38M
Cash & Equivalents	11.32M	27.05M	1.88M	3.96M	5.68M	15.58M	13.07M	9.58M	10.62M	15.15M	13.86M	82.98M	29.21M	-	64.52M	32.94M	10.65M	33.97M
Inventory	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Receivables	-	-	-	-	-	-	-	-	-	-	-	-	-	-	944.38M	741.19M	508.30M	430.60M
Total Liabilities	-	-	380.28M	375.90M	335.27M	386.55M	424.15M	532.57M	737.50M	691.43M	853.73M	1.19B	1.53B	-	1.84B	2.09B	1.71B	1.45B
Current Liabilities	-	-	117.89M	140.05M	109.53M	143.09M	178.29M	251.02M	274.79M	265.27M	307.27M	378.11M	422.96M	-	857.93M	656.12M	545.78M	577.61M
Long Term Debt	-	-	-	174.20M	158.18M	148.67M	-	-	-	-	-	-	-	-	843.50M	1.30B	1.06B	767.05M
Total Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	860.96M	1.35B	1.10B	803.20M
Total Equity	284.13M	170.84M	153.46M	135.66M	182.11M	217.74M	256.58M	347.86M	449.38M	562.53M	638.99M	736.74M	819.68M	-	1.04B	831.26M	706.62M	642.11M
Shares Outstanding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	50.11M	50.42M	50.69M	51.05M

Cash Flows (Annual)

Figures in USD.

Metric	Dec 2009	Dec 2010	Dec 2011	Dec 2012	Dec 2013	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Operating Cash Flow	98.73M	8.09M	19.31M	58.38M	60.17M	27.68M	56.31M	133.91M	160.52M	226.99M	224.86M	256.83M	-	653.73M	372.17M	320.42M	269.46M
Investing Cash Flow	-29.25M	-6.85M	-1.98M	1.58M	-49.20M	-28.23M	-116.08M	-258.36M	-35.36M	-279.34M	-291.82M	-538.17M	-	-170.71M	-412.49M	-79.94M	4.30M
Financing Cash Flow	-53.81M	-26.45M	-15.30M	-58.17M	-1.02M	-2.10M	56.20M	126.29M	-77.19M	37.51M	136.60M	211.49M	-	-591.87M	10.73M	-259.45M	-295.89M
Capital Expenditure	-3.79M	-4.17M	-4.65M	-5.47M	-9.05M	-19.13M	-27.01M	-21.96M	-26.53M	-35.21M	-35.22M	-37.70M	-	-80.92M	-105.39M	-80.89M	-35.63M
Free Cash Flow	94.94M	3.92M	14.66M	52.91M	51.12M	8.54M	29.30M	111.95M	133.99M	191.79M	189.64M	219.12M	-	572.81M	266.78M	239.53M	233.83M
Net Change in Cash	-	-	-	-	-	-	-	-	-	-	-	-	-	-108.84M	-29.60M	-18.97M	-22.13M
Share Buybacks	-	-	-	-	-	0	0	13.26M	20.16M	67.01M	18.70M	0	2.69M	576.77M	424.74M	0	0

Ratios (Annual)

Figures in %.

Metric	Dec 2009	Dec 2010	Dec 2011	Dec 2012	Dec 2013	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Gross Margin %	-	-	-	-	-	-	-	32.6%	32.4%	32.6%	33.5%	33.1%	32.9%	32.7%	33.0%	30.8%	28.3%
Operating Margin %	-	-	-	-	-	-	-	10.1%	10.7%	9.5%	8.0%	6.2%	12.0%	12.3%	9.1%	4.0%	1.2%
Net Margin %	-	-	-	-	-	-	-	5.6%	6.7%	6.6%	5.1%	3.0%	8.2%	8.5%	5.6%	-4.9%	-3.5%
ROE %	-71.5%	-33.9%	-19.4%	9.4%	15.1%	12.9%	23.5%	23.6%	23.6%	22.2%	15.5%	8.6%	-	42.5%	25.3%	-20.8%	-14.9%
ROCE %	-	-9.9%	9.5%	13.1%	14.2%	13.5%	20.5%	21.0%	21.5%	17.1%	11.4%	7.7%	-	31.9%	15.3%	6.4%	2.2%

Shareholding Pattern

Insiders

0.99%

Institutions

115.55%

Public Float

116.70%

Top Institutional Holders

#	Holder	% Held	Shares	Value
1	Blackrock Inc.	15.53%	6.02M	$174.50M
2	Boston Partners	5.51%	2.14M	$61.95M
3	Vanguard Capital Management LLC	4.32%	1.68M	$48.60M
4	State Street Corporation	4.16%	1.61M	$46.77M
5	Two Sigma Investments, LP	4.09%	1.59M	$46.00M
6	Arrowstreet Capital, Limited Partnership	3.61%	1.40M	$40.61M
7	Renaissance Technologies, LLC	3.55%	1.38M	$39.87M
8	Morgan Stanley	3.46%	1.34M	$38.84M
9	Allianz Asset Management GmbH	3.25%	1.26M	$36.53M
10	Vanguard Portfolio Management LLC	2.90%	1.12M	$32.58M

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for AMN

No recent headlines available.

AMN · Healthcare